Open Access
MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3 [Retraction]
American Journal of Cancer Research · 2026 · 16 (4) · 1695-1695
DOI: 10.62347/qfeh4330 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Guo-Qing Sui und 6 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sui, G., Fei, D., Guo, F., Zhen, X., Luo, Q., Yin, S., & Wang, H. (2026). MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3 [Retraction]. American Journal of Cancer Research, 16(4), 1695-1695. https://doi.org/10.62347/qfeh4330
Vancouver
Sui G, Fei D, Guo F, Zhen X, Luo Q, Yin S, et al. MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3 [Retraction]. American Journal of Cancer Research. 2026;16(4):1695-1695. doi:10.62347/qfeh4330
BibTeX
@article{Sui2026,
author = {Sui, Guo-Qing and Fei, Dan and Guo, Feng and Zhen, Xi and Luo, Qiang and Yin, Shuai and Wang, Hui},
title = {MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3 [Retraction]},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {4},
pages = {1695--1695},
doi = {10.62347/qfeh4330}
}
EUVIMED